Outcomes and clinicopathologic characteristics associated with disseminated tumor cells in bone marrow after neoadjuvant chemotherapy in high-risk early stage breast cancer: the I-SPY SURMOUNT study

[1] Abravanel DL(2015)Notch promotes recurrence of dormant tumor cells following HER2/neu-targeted therapy J Clin Invest 125 2484-2496

[2] Belka GK(2018)Emerging topics on disseminated cancer cell dormancy and the paradigm of metastasis Annual Review of Cancer Biology 2 377-393

[3] Pan TC(2013)Par-4 downregulation promotes breast cancer recurrence by preventing multinucleation following targeted therapy Cancer Cell 24 30-44

[4] Pant DK(2021)Abstract PD9–11: identifying breast cancer survivors with dormant disseminated tumor cells: the PENN-SURMOUNT screening study Cancer Res 81 1-533

[5] Collins MA(2000)Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer N Engl J Med 342 525-802

[6] Sterner CJ(2005)A pooled analysis of bone marrow micrometastasis in breast cancer N Engl J Med 353 793-171

[7] Chodosh LA(2005)Immune dysfunction and micrometastases in women with breast cancer Breast Cancer Res Treat 91 163-892

[8] Aguirre-Ghiso JA(2006)A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation Cancer 107 885-348

[9] Sosa MS(2012)Disseminated tumor cells predict survival after neoadjuvant therapy in primary breast cancer Cancer 118 342-558

[10] Alvarez JV(2013)The presence and prognostic impact of apoptotic and nonapoptotic disseminated tumor cells in the bone marrow of primary breast cancer patients after neoadjuvant chemotherapy Breast Cancer Res 15 R94-24687

[1] Abravanel DL(2015)Notch promotes recurrence of dormant tumor cells following HER2/neu-targeted therapy J Clin Invest 125 2484-2496

[2] Belka GK(2018)Emerging topics on disseminated cancer cell dormancy and the paradigm of metastasis Annual Review of Cancer Biology 2 377-393

[3] Pan TC(2013)Par-4 downregulation promotes breast cancer recurrence by preventing multinucleation following targeted therapy Cancer Cell 24 30-44

[4] Pant DK(2021)Abstract PD9–11: identifying breast cancer survivors with dormant disseminated tumor cells: the PENN-SURMOUNT screening study Cancer Res 81 1-533

[5] Collins MA(2000)Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer N Engl J Med 342 525-802

[6] Sterner CJ(2005)A pooled analysis of bone marrow micrometastasis in breast cancer N Engl J Med 353 793-171

[7] Chodosh LA(2005)Immune dysfunction and micrometastases in women with breast cancer Breast Cancer Res Treat 91 163-892

[8] Aguirre-Ghiso JA(2006)A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation Cancer 107 885-348

[9] Sosa MS(2012)Disseminated tumor cells predict survival after neoadjuvant therapy in primary breast cancer Cancer 118 342-558

[10] Alvarez JV(2013)The presence and prognostic impact of apoptotic and nonapoptotic disseminated tumor cells in the bone marrow of primary breast cancer patients after neoadjuvant chemotherapy Breast Cancer Res 15 R94-24687